BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29956001)

  • 1. The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
    Tornic J; Panicker JN
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):54. PubMed ID: 29956001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options].
    Mehnert U; Nehiba M
    Urologe A; 2012 Feb; 51(2):189-97. PubMed ID: 22331072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
    Sakakibara R
    Clin Auton Res; 2019 Jun; 29(3):313-320. PubMed ID: 30076494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
    Sand PK; Sand RI
    Dis Mon; 2013 Jul; 59(7):261-8. PubMed ID: 23786660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamics in the evaluation of the patient with multiple sclerosis: when are they helpful and how do we use them?
    Dillon BE; Lemack GE
    Urol Clin North Am; 2014 Aug; 41(3):439-44, ix. PubMed ID: 25063600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
    Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
    Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voiding Phase Dysfunction in Multiple Sclerosis: Contemporary Review of Terminology, Diagnosis, Management, and Future Directions.
    Ingram CF; Lincoln JA; Khavari R
    Urol Clin North Am; 2024 May; 51(2):177-185. PubMed ID: 38609190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management.
    Panicker JN; Fowler CJ; Kessler TM
    Lancet Neurol; 2015 Jul; 14(7):720-32. PubMed ID: 26067125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
    Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
    Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis.
    Tomé ALF; Miranda EP; de Bessa Júnior J; Bezerra CA; Pompeo ACL; Glina S; Gomes CM
    Clinics (Sao Paulo); 2019 Mar; 74():e713. PubMed ID: 30892415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neurogenic bladder in patients with multiple sclerosis.
    Phé V; Chartier-Kastler E; Panicker JN
    Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.
    Çetinel B; Tarcan T; Demirkesen O; Özyurt C; Şen İ; Erdoğan S; Siva A
    Neurourol Urodyn; 2013 Nov; 32(8):1047-57. PubMed ID: 23757108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do patients with symptoms and signs of lower urinary tract dysfunction need a urodynamic diagnosis? ICI-RS 2013.
    Rosier PF; Giarenis I; Valentini FA; Wein A; Cardozo L
    Neurourol Urodyn; 2014 Jun; 33(5):581-6. PubMed ID: 24844430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
    Dray E; Cameron AP; Clemens JQ; Qin Y; Covalschi D; Stoffel J
    J Urol; 2018 Oct; 200(4):868-874. PubMed ID: 29702098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between lower urinary tract dysfunction and glycemic control in women with type 2 diabetes: A cross-sectional study.
    Tai HC; Tai TY; Yang WS; Wang SW; Yu HJ
    J Diabetes Complications; 2016 Apr; 30(3):415-9. PubMed ID: 26861946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower urinary tract dysfunction in patients with functional movement disorders.
    Batla A; Pareés I; Edwards MJ; Stamelou M; Bhatia KP; Panicker JN
    J Neurol Sci; 2016 Feb; 361():192-4. PubMed ID: 26810540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Lower Urinary Tract Dysfunction.
    McDonough RC; Ryan ST
    Surg Clin North Am; 2016 Jun; 96(3):441-52. PubMed ID: 27261787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.
    Tubaro A; Puccini F; De Nunzio C; Digesu GA; Elneil S; Gobbi C; Khullar V
    Curr Urol Rep; 2012 Oct; 13(5):335-42. PubMed ID: 22886612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower urinary tract dysfunction in patients with multiple sclerosis: A post-void residual analysis of 501 cases.
    Monti Bragadin M; Motta R; Messmer Uccelli M; Tacchino A; Ponzio M; Podda J; Konrad G; Rinaldi S; Della Cava M; Battaglia MA; Brichetto G
    Mult Scler Relat Disord; 2020 Oct; 45():102378. PubMed ID: 32683303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Ineichen BV; Schneider MP; Hlavica M; Hagenbuch N; Linnebank M; Kessler TM
    Mult Scler; 2018 Apr; 24(4):529-534. PubMed ID: 28367674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.